(Eusa) New data show that CAPHOSOL(R) significantly limits the occurrence and severity of oral mucositis in cancer patients undergoing chemotherapy and radiation therapy.
The data also demonstrate that CAPHOSOL use is associated with high levels of medication compliance and patient and physician satisfaction.
The latest findings expand upon the growing body of evidence of the benefits of CAPHOSOL in the management of OM and related symptoms in patients with various types of cancer.